Loganin attenuates neuroinflammation after ischemic stroke and fracture by regulating α7nAChR‐mediated microglial polarization
Fracture in acute stage of ischemic stroke can increase inflammatory response and enhance stroke injury. Loganin alleviates the symptoms of many inflammatory diseases through its anti‐inflammatory effect, but its role in ischemic stroke and fracture remains to be explored. Here, mice were handled wi...
Gespeichert in:
Veröffentlicht in: | Environmental toxicology 2023-03, Vol.38 (4), p.926-940 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 940 |
---|---|
container_issue | 4 |
container_start_page | 926 |
container_title | Environmental toxicology |
container_volume | 38 |
creator | Huo, Kang Xu, Jing Ma, Kaige Wang, Jianyi Wei, Meng Zhang, Meng Guo, Qinyue Qu, Qiumin |
description | Fracture in acute stage of ischemic stroke can increase inflammatory response and enhance stroke injury. Loganin alleviates the symptoms of many inflammatory diseases through its anti‐inflammatory effect, but its role in ischemic stroke and fracture remains to be explored. Here, mice were handled with permanent middle cerebral artery occlusion (pMCAO) followed by tibial fracture 1 day later to establish a pMCAO+fracture model. Loganin or Methyllycaconitine (MLA, a specific a7nAchR inhibitor) were intragastrically administered 2 or 0.5 h before pMCAO, respectively. And mouse motor function and infarct volume were evaluated 3 days after pMCAO. We found that loganin alleviated the neurological deficit, cerebral infarction volume, and neuronal apoptosis (NeuN+TUNEL+) in mice with pMCAO+fracture. And loganin suppressed pMCAO+fracture‐induced neuroinflammation by promoting M2 microglia polarization (Iba1+CD206+) and inhibiting M1 microglia polarization (Iba1+CD11b+). While administration with MLA reversed the protective effect of loganin on pMCAO+fracture‐induced neurological deficit and neuroinflammation. Next, LPS was used to stimulate BV2 microglia to simulate pMCAO+fracture‐induced inflammatory microenvironment in vitro. Loganin facilitated the transformation of LPS‐stimulated BV2 cells from M1 pro‐inflammatory state (CD11b+) to M2 anti‐inflammatory state (CD206+), which was antagonized by treatment with MLA. And loganin induced autophagy activation in LPS‐stimulated BV2 cells by activating a7nAchR. Moreover, treatment with rapamycin (an autophagy activator) neutralized the inhibitory effect of MLA on loganin induced transformation of BV2 cells to M2 phenotype. Furthermore, BV2 cells were treated with LPS, LPS + loganin, LPS + loganin+MLA, or LPS + loganin+MLA+ rapamycin to obtain conditioned medium (CM) for stimulating primary neurons. Loganin reduced the damage of primary neurons caused by LPS‐stimulated BV2 microglia through activating a7nAchR and inducing autophagy activation. In conclusion, loganin played anti‐inflammatory and neuroprotective roles in pMCAO + fracture mice by activating a7nAchR, enhancing autophagy and promoting M2 polarization of microglia. |
doi_str_mv | 10.1002/tox.23738 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2765775785</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2785182583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3538-6c6652ce568946485f860a282eb0959a6e6fde8bead927aee618374fb2736d563</originalsourceid><addsrcrecordid>eNp1kUtOHDEQhq0IFAjJIhdAlrIhiwa3PX70Eo3CQxoJCREpu5a7u3owcduD7RYZVnCDXCUX4RCcBDMDLCKxckn-6lNV_Qh9Lcl-SQg9SP7PPmWSqQ9ou-SUFpJKtbGqSTEhqtxCn2K8IoRUgouPaIsJwWTJyTa6n_m5dsZhnRK4USeI2MEYvHG91cOgk_H5s08QsIntJQymxTEF_xuwdh3ug27TGAA3SxxgPtrc4Ob44Z90h9PL88e7vwN0Jms7nDuDn1ujLV54q4O5Xck_o81e2whfXt4d9PPox8X0pJidHZ9OD2dFyzhThWiF4LQFLlQ1ERPFeyWIpopCQypeaQGi70A1oLuKSg0gSsXkpG-oZKLjgu2gvbV3Efz1CDHVQ14IrNUO_BhrKgWXkkvFM_rtP_TKj8Hl6TKleKkoVyxT39dUXivGAH29CGbQYVmXpH7Opc651KtcMrv7YhybfJA38jWIDBysgRtjYfm-qb44-7VWPgEQkJst</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2785182583</pqid></control><display><type>article</type><title>Loganin attenuates neuroinflammation after ischemic stroke and fracture by regulating α7nAChR‐mediated microglial polarization</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Huo, Kang ; Xu, Jing ; Ma, Kaige ; Wang, Jianyi ; Wei, Meng ; Zhang, Meng ; Guo, Qinyue ; Qu, Qiumin</creator><creatorcontrib>Huo, Kang ; Xu, Jing ; Ma, Kaige ; Wang, Jianyi ; Wei, Meng ; Zhang, Meng ; Guo, Qinyue ; Qu, Qiumin</creatorcontrib><description>Fracture in acute stage of ischemic stroke can increase inflammatory response and enhance stroke injury. Loganin alleviates the symptoms of many inflammatory diseases through its anti‐inflammatory effect, but its role in ischemic stroke and fracture remains to be explored. Here, mice were handled with permanent middle cerebral artery occlusion (pMCAO) followed by tibial fracture 1 day later to establish a pMCAO+fracture model. Loganin or Methyllycaconitine (MLA, a specific a7nAchR inhibitor) were intragastrically administered 2 or 0.5 h before pMCAO, respectively. And mouse motor function and infarct volume were evaluated 3 days after pMCAO. We found that loganin alleviated the neurological deficit, cerebral infarction volume, and neuronal apoptosis (NeuN+TUNEL+) in mice with pMCAO+fracture. And loganin suppressed pMCAO+fracture‐induced neuroinflammation by promoting M2 microglia polarization (Iba1+CD206+) and inhibiting M1 microglia polarization (Iba1+CD11b+). While administration with MLA reversed the protective effect of loganin on pMCAO+fracture‐induced neurological deficit and neuroinflammation. Next, LPS was used to stimulate BV2 microglia to simulate pMCAO+fracture‐induced inflammatory microenvironment in vitro. Loganin facilitated the transformation of LPS‐stimulated BV2 cells from M1 pro‐inflammatory state (CD11b+) to M2 anti‐inflammatory state (CD206+), which was antagonized by treatment with MLA. And loganin induced autophagy activation in LPS‐stimulated BV2 cells by activating a7nAchR. Moreover, treatment with rapamycin (an autophagy activator) neutralized the inhibitory effect of MLA on loganin induced transformation of BV2 cells to M2 phenotype. Furthermore, BV2 cells were treated with LPS, LPS + loganin, LPS + loganin+MLA, or LPS + loganin+MLA+ rapamycin to obtain conditioned medium (CM) for stimulating primary neurons. Loganin reduced the damage of primary neurons caused by LPS‐stimulated BV2 microglia through activating a7nAchR and inducing autophagy activation. In conclusion, loganin played anti‐inflammatory and neuroprotective roles in pMCAO + fracture mice by activating a7nAchR, enhancing autophagy and promoting M2 polarization of microglia.</description><identifier>ISSN: 1520-4081</identifier><identifier>EISSN: 1522-7278</identifier><identifier>DOI: 10.1002/tox.23738</identifier><identifier>PMID: 36637150</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>alpha7 Nicotinic Acetylcholine Receptor ; Animals ; Anti-Inflammatory Agents - pharmacology ; Apoptosis ; Autophagy ; CD11b antigen ; Cells ; Cerebral blood flow ; Cerebral infarction ; Genetic transformation ; Inflammatory diseases ; Inflammatory response ; Ischemia ; Ischemic Stroke ; Lipopolysaccharides ; Lipopolysaccharides - pharmacology ; loganin ; Methyllycaconitine ; Mice ; Microglia ; microglia polarization ; Neuroinflammatory Diseases ; Neurons ; Neuroprotection ; Occlusion ; permanent middle cerebral artery occlusion + fracture ; Phenotypes ; Polarization ; Rapamycin ; Signs and symptoms ; Stroke ; Symptoms ; α7nAChR</subject><ispartof>Environmental toxicology, 2023-03, Vol.38 (4), p.926-940</ispartof><rights>2023 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3538-6c6652ce568946485f860a282eb0959a6e6fde8bead927aee618374fb2736d563</citedby><cites>FETCH-LOGICAL-c3538-6c6652ce568946485f860a282eb0959a6e6fde8bead927aee618374fb2736d563</cites><orcidid>0000-0002-6416-6961</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Ftox.23738$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Ftox.23738$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36637150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huo, Kang</creatorcontrib><creatorcontrib>Xu, Jing</creatorcontrib><creatorcontrib>Ma, Kaige</creatorcontrib><creatorcontrib>Wang, Jianyi</creatorcontrib><creatorcontrib>Wei, Meng</creatorcontrib><creatorcontrib>Zhang, Meng</creatorcontrib><creatorcontrib>Guo, Qinyue</creatorcontrib><creatorcontrib>Qu, Qiumin</creatorcontrib><title>Loganin attenuates neuroinflammation after ischemic stroke and fracture by regulating α7nAChR‐mediated microglial polarization</title><title>Environmental toxicology</title><addtitle>Environ Toxicol</addtitle><description>Fracture in acute stage of ischemic stroke can increase inflammatory response and enhance stroke injury. Loganin alleviates the symptoms of many inflammatory diseases through its anti‐inflammatory effect, but its role in ischemic stroke and fracture remains to be explored. Here, mice were handled with permanent middle cerebral artery occlusion (pMCAO) followed by tibial fracture 1 day later to establish a pMCAO+fracture model. Loganin or Methyllycaconitine (MLA, a specific a7nAchR inhibitor) were intragastrically administered 2 or 0.5 h before pMCAO, respectively. And mouse motor function and infarct volume were evaluated 3 days after pMCAO. We found that loganin alleviated the neurological deficit, cerebral infarction volume, and neuronal apoptosis (NeuN+TUNEL+) in mice with pMCAO+fracture. And loganin suppressed pMCAO+fracture‐induced neuroinflammation by promoting M2 microglia polarization (Iba1+CD206+) and inhibiting M1 microglia polarization (Iba1+CD11b+). While administration with MLA reversed the protective effect of loganin on pMCAO+fracture‐induced neurological deficit and neuroinflammation. Next, LPS was used to stimulate BV2 microglia to simulate pMCAO+fracture‐induced inflammatory microenvironment in vitro. Loganin facilitated the transformation of LPS‐stimulated BV2 cells from M1 pro‐inflammatory state (CD11b+) to M2 anti‐inflammatory state (CD206+), which was antagonized by treatment with MLA. And loganin induced autophagy activation in LPS‐stimulated BV2 cells by activating a7nAchR. Moreover, treatment with rapamycin (an autophagy activator) neutralized the inhibitory effect of MLA on loganin induced transformation of BV2 cells to M2 phenotype. Furthermore, BV2 cells were treated with LPS, LPS + loganin, LPS + loganin+MLA, or LPS + loganin+MLA+ rapamycin to obtain conditioned medium (CM) for stimulating primary neurons. Loganin reduced the damage of primary neurons caused by LPS‐stimulated BV2 microglia through activating a7nAchR and inducing autophagy activation. In conclusion, loganin played anti‐inflammatory and neuroprotective roles in pMCAO + fracture mice by activating a7nAchR, enhancing autophagy and promoting M2 polarization of microglia.</description><subject>alpha7 Nicotinic Acetylcholine Receptor</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>CD11b antigen</subject><subject>Cells</subject><subject>Cerebral blood flow</subject><subject>Cerebral infarction</subject><subject>Genetic transformation</subject><subject>Inflammatory diseases</subject><subject>Inflammatory response</subject><subject>Ischemia</subject><subject>Ischemic Stroke</subject><subject>Lipopolysaccharides</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>loganin</subject><subject>Methyllycaconitine</subject><subject>Mice</subject><subject>Microglia</subject><subject>microglia polarization</subject><subject>Neuroinflammatory Diseases</subject><subject>Neurons</subject><subject>Neuroprotection</subject><subject>Occlusion</subject><subject>permanent middle cerebral artery occlusion + fracture</subject><subject>Phenotypes</subject><subject>Polarization</subject><subject>Rapamycin</subject><subject>Signs and symptoms</subject><subject>Stroke</subject><subject>Symptoms</subject><subject>α7nAChR</subject><issn>1520-4081</issn><issn>1522-7278</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtOHDEQhq0IFAjJIhdAlrIhiwa3PX70Eo3CQxoJCREpu5a7u3owcduD7RYZVnCDXCUX4RCcBDMDLCKxckn-6lNV_Qh9Lcl-SQg9SP7PPmWSqQ9ou-SUFpJKtbGqSTEhqtxCn2K8IoRUgouPaIsJwWTJyTa6n_m5dsZhnRK4USeI2MEYvHG91cOgk_H5s08QsIntJQymxTEF_xuwdh3ug27TGAA3SxxgPtrc4Ob44Z90h9PL88e7vwN0Jms7nDuDn1ujLV54q4O5Xck_o81e2whfXt4d9PPox8X0pJidHZ9OD2dFyzhThWiF4LQFLlQ1ERPFeyWIpopCQypeaQGi70A1oLuKSg0gSsXkpG-oZKLjgu2gvbV3Efz1CDHVQ14IrNUO_BhrKgWXkkvFM_rtP_TKj8Hl6TKleKkoVyxT39dUXivGAH29CGbQYVmXpH7Opc651KtcMrv7YhybfJA38jWIDBysgRtjYfm-qb44-7VWPgEQkJst</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Huo, Kang</creator><creator>Xu, Jing</creator><creator>Ma, Kaige</creator><creator>Wang, Jianyi</creator><creator>Wei, Meng</creator><creator>Zhang, Meng</creator><creator>Guo, Qinyue</creator><creator>Qu, Qiumin</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QH</scope><scope>7ST</scope><scope>7TN</scope><scope>7U7</scope><scope>7UA</scope><scope>C1K</scope><scope>F1W</scope><scope>H97</scope><scope>K9.</scope><scope>L.G</scope><scope>M7N</scope><scope>SOI</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6416-6961</orcidid></search><sort><creationdate>202303</creationdate><title>Loganin attenuates neuroinflammation after ischemic stroke and fracture by regulating α7nAChR‐mediated microglial polarization</title><author>Huo, Kang ; Xu, Jing ; Ma, Kaige ; Wang, Jianyi ; Wei, Meng ; Zhang, Meng ; Guo, Qinyue ; Qu, Qiumin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3538-6c6652ce568946485f860a282eb0959a6e6fde8bead927aee618374fb2736d563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>alpha7 Nicotinic Acetylcholine Receptor</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>CD11b antigen</topic><topic>Cells</topic><topic>Cerebral blood flow</topic><topic>Cerebral infarction</topic><topic>Genetic transformation</topic><topic>Inflammatory diseases</topic><topic>Inflammatory response</topic><topic>Ischemia</topic><topic>Ischemic Stroke</topic><topic>Lipopolysaccharides</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>loganin</topic><topic>Methyllycaconitine</topic><topic>Mice</topic><topic>Microglia</topic><topic>microglia polarization</topic><topic>Neuroinflammatory Diseases</topic><topic>Neurons</topic><topic>Neuroprotection</topic><topic>Occlusion</topic><topic>permanent middle cerebral artery occlusion + fracture</topic><topic>Phenotypes</topic><topic>Polarization</topic><topic>Rapamycin</topic><topic>Signs and symptoms</topic><topic>Stroke</topic><topic>Symptoms</topic><topic>α7nAChR</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huo, Kang</creatorcontrib><creatorcontrib>Xu, Jing</creatorcontrib><creatorcontrib>Ma, Kaige</creatorcontrib><creatorcontrib>Wang, Jianyi</creatorcontrib><creatorcontrib>Wei, Meng</creatorcontrib><creatorcontrib>Zhang, Meng</creatorcontrib><creatorcontrib>Guo, Qinyue</creatorcontrib><creatorcontrib>Qu, Qiumin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aqualine</collection><collection>Environment Abstracts</collection><collection>Oceanic Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Water Resources Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Environmental toxicology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huo, Kang</au><au>Xu, Jing</au><au>Ma, Kaige</au><au>Wang, Jianyi</au><au>Wei, Meng</au><au>Zhang, Meng</au><au>Guo, Qinyue</au><au>Qu, Qiumin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Loganin attenuates neuroinflammation after ischemic stroke and fracture by regulating α7nAChR‐mediated microglial polarization</atitle><jtitle>Environmental toxicology</jtitle><addtitle>Environ Toxicol</addtitle><date>2023-03</date><risdate>2023</risdate><volume>38</volume><issue>4</issue><spage>926</spage><epage>940</epage><pages>926-940</pages><issn>1520-4081</issn><eissn>1522-7278</eissn><abstract>Fracture in acute stage of ischemic stroke can increase inflammatory response and enhance stroke injury. Loganin alleviates the symptoms of many inflammatory diseases through its anti‐inflammatory effect, but its role in ischemic stroke and fracture remains to be explored. Here, mice were handled with permanent middle cerebral artery occlusion (pMCAO) followed by tibial fracture 1 day later to establish a pMCAO+fracture model. Loganin or Methyllycaconitine (MLA, a specific a7nAchR inhibitor) were intragastrically administered 2 or 0.5 h before pMCAO, respectively. And mouse motor function and infarct volume were evaluated 3 days after pMCAO. We found that loganin alleviated the neurological deficit, cerebral infarction volume, and neuronal apoptosis (NeuN+TUNEL+) in mice with pMCAO+fracture. And loganin suppressed pMCAO+fracture‐induced neuroinflammation by promoting M2 microglia polarization (Iba1+CD206+) and inhibiting M1 microglia polarization (Iba1+CD11b+). While administration with MLA reversed the protective effect of loganin on pMCAO+fracture‐induced neurological deficit and neuroinflammation. Next, LPS was used to stimulate BV2 microglia to simulate pMCAO+fracture‐induced inflammatory microenvironment in vitro. Loganin facilitated the transformation of LPS‐stimulated BV2 cells from M1 pro‐inflammatory state (CD11b+) to M2 anti‐inflammatory state (CD206+), which was antagonized by treatment with MLA. And loganin induced autophagy activation in LPS‐stimulated BV2 cells by activating a7nAchR. Moreover, treatment with rapamycin (an autophagy activator) neutralized the inhibitory effect of MLA on loganin induced transformation of BV2 cells to M2 phenotype. Furthermore, BV2 cells were treated with LPS, LPS + loganin, LPS + loganin+MLA, or LPS + loganin+MLA+ rapamycin to obtain conditioned medium (CM) for stimulating primary neurons. Loganin reduced the damage of primary neurons caused by LPS‐stimulated BV2 microglia through activating a7nAchR and inducing autophagy activation. In conclusion, loganin played anti‐inflammatory and neuroprotective roles in pMCAO + fracture mice by activating a7nAchR, enhancing autophagy and promoting M2 polarization of microglia.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>36637150</pmid><doi>10.1002/tox.23738</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-6416-6961</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1520-4081 |
ispartof | Environmental toxicology, 2023-03, Vol.38 (4), p.926-940 |
issn | 1520-4081 1522-7278 |
language | eng |
recordid | cdi_proquest_miscellaneous_2765775785 |
source | MEDLINE; Wiley Journals |
subjects | alpha7 Nicotinic Acetylcholine Receptor Animals Anti-Inflammatory Agents - pharmacology Apoptosis Autophagy CD11b antigen Cells Cerebral blood flow Cerebral infarction Genetic transformation Inflammatory diseases Inflammatory response Ischemia Ischemic Stroke Lipopolysaccharides Lipopolysaccharides - pharmacology loganin Methyllycaconitine Mice Microglia microglia polarization Neuroinflammatory Diseases Neurons Neuroprotection Occlusion permanent middle cerebral artery occlusion + fracture Phenotypes Polarization Rapamycin Signs and symptoms Stroke Symptoms α7nAChR |
title | Loganin attenuates neuroinflammation after ischemic stroke and fracture by regulating α7nAChR‐mediated microglial polarization |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T15%3A00%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Loganin%20attenuates%20neuroinflammation%20after%20ischemic%20stroke%20and%20fracture%20by%20regulating%20%CE%B17nAChR%E2%80%90mediated%20microglial%20polarization&rft.jtitle=Environmental%20toxicology&rft.au=Huo,%20Kang&rft.date=2023-03&rft.volume=38&rft.issue=4&rft.spage=926&rft.epage=940&rft.pages=926-940&rft.issn=1520-4081&rft.eissn=1522-7278&rft_id=info:doi/10.1002/tox.23738&rft_dat=%3Cproquest_cross%3E2785182583%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2785182583&rft_id=info:pmid/36637150&rfr_iscdi=true |